Cognitive impairment, fatigue and depression in multiple sclerosis: Is there a difference between benign and non-benign MS?

被引:8
作者
Bogaardt, Hans [1 ]
Golan, Daniel [2 ,3 ]
Barrera, Marissa A. [4 ]
Attrill, Stacie [1 ]
Kaczmarek, Olivia [5 ]
Zarif, Myassar [5 ]
Bumstead, Barbara [5 ]
Buhse, Marijean [5 ,6 ]
Wilken, Jeffrey [7 ,8 ]
Doniger, Glen M. [9 ]
Hancock, Laura M. [10 ]
Penner, Iris-Katharina [11 ]
Halper, June [12 ]
Morrow, Sarah A. [13 ]
Covey, Thomas J. [14 ,15 ]
Gudesblatt, Mark
机构
[1] Univ Adelaide, Sch Allied Hlth Sci & Practice, Adelaide, Australia
[2] Clalit Hlth Serv, Multiple Sclerosis & Neuroimmunol Ctr, Nazareth, Israel
[3] Technion Israel Inst Technol, Rappaport Fac Med, Lady Davis Carmel Med Ctr, Dept Neurol, Haifa, Israel
[4] Yeshiva Univ, Katz Sch Sci & Hlth, New York, NY USA
[5] South Shore Neurol Associates, New York, NY USA
[6] SUNY Stony Brook, Dept Nursing, Stony Brook, NY USA
[7] Georgetown Univ, Dept Neurol, Washington, DC USA
[8] Washington Neuropsychol Res Grp LLC, Fairfax, VA USA
[9] NeuroTrax Corp, Dept Clin Res, Modiin, Israel
[10] Univ Wisconsin, Dept Neurol, Sch Med & Publ Hlth, Madison, WI USA
[11] Univ Bern, Bern Univ Hosp, Dept Neurol, Inselspital, Bern, Switzerland
[12] Consortium Multiple Sclerosis Ctr, Hackensack, NJ USA
[13] Univ Western Ontario Western, Univ Hosp, London Hlth Sci Ctr, London, ON, Canada
[14] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurol, Div Cognit & Behav Neurosci, Buffalo, NY USA
[15] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Neurosci Program, Buffalo, NY USA
关键词
SEVERITY SCALE;
D O I
10.1016/j.msard.2023.104630
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Multiple Sclerosis (MS) is a chronic inflammatory and degenerative disease of the central nervous system (CNS). The severity of disability in people with MS (PwMS) is generally measured with the Expanded Disability Status Scale (EDSS). A variant of MS known as 'benign MS' (BMS) has been defined as an EDSS score of 3 or lower, combined with a disease duration of 10 years or longer; however, there is disagreement in the field about whether BMS really exists. Given that the EDSS does not capture cognitive issues, communication dysfunction, fatigue, depression, or anxiety properly, its ability to accurately represent disability in all PwMS, including BMS, remains questionable.Methods: In this study, 141 persons with BMS (PwBMS) were included, consisting of 115 females (82%) and 26 males (18%) with a mean age of 50.8 (+/- 8.68). A computerized test battery (NeuroTrax (R)) was used to assess cognition, covering seven cognitive domains (memory, executive function, visual-spatial processing, verbal function, attention, information processing, and motor skills). Fatigue was measured using the Fatigue Severity Scale (FSS). The Beck Depression Inventory (BDI) was used to assess symptoms of depression. Cognitive impairment was defined for this study as when someone has a score lower than 85 in at least two subdomains of the cognitive test battery. Rates of impairment were compared to 158 persons with non-benign MS (PwNBMS; with a disease duration of 10 years and longer and an EDSS score higher than 3) and 487 PwMS with a disease duration of fewer than 10 years.Results: Cognitive impairment was found in 38% of PwBMS and in 66% of PwNBMS (p<0.001). In PwBMS, the lowest rate of impairment was found in the verbal function domain (18%) and the highest rate of impairment in the domain of information processing (32%). Fatigue and depression were found in 78% and 55% of all PwBMS, with no difference in these rates between PwBMS and PwNBMS (p = 0.787 and p = 0.316 resp.)Conclusion: Cognitive impairment, fatigue and depression are common among people with an EDSS-based definition of benign MS. These aspects should be incor-porated into a new and better definition of truly benign MS
引用
收藏
页数:7
相关论文
共 39 条
  • [1] Prolonged response times characterize cognitive performance in multiple sclerosis
    Achiron, A.
    Doniger, G. M.
    Harel, Y.
    Appleboim-Gavish, N.
    Lavie, M.
    Simon, E. S.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (10) : 1102 - 1108
  • [2] Alali D., 2020, NEUROLOGIC NEURODEGE, P171, DOI [10.1007/978-3-030-28852-5_14, DOI 10.1007/978-3-030-28852-5_14]
  • [3] Alonso Ricardo N, 2020, Int J MS Care, V22, P31, DOI 10.7224/1537-2073.2018-084
  • [4] Benign multiple sclerosis - Cognitive, psychological and social aspects in a clinical cohort
    Amato, Maria Pia
    Zipoli, Valentina
    Goretti, Benedetta
    Portaccio, Emilio
    De Caro, Maria Fara
    Ricchiuti, Laura
    Siracusa, Gianfranco
    Masini, Medena
    Sorbi, Sandro
    Trojano, Maria
    [J]. JOURNAL OF NEUROLOGY, 2006, 253 (08) : 1054 - 1059
  • [5] Truly benign multiple sclerosis is rare: let's stop fooling ourselves-Yes
    Amato, Maria Pia
    Portaccio, Emilio
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (01) : 13 - 14
  • [6] Barrera M., 2017, EFFECT SINGLE BOUT P
  • [7] AN INVENTORY FOR MEASURING DEPRESSION
    BECK, AT
    ERBAUGH, J
    WARD, CH
    MOCK, J
    MENDELSOHN, M
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) : 561 - &
  • [8] SET CORRELATION AND CONTINGENCY-TABLES
    COHEN, J
    [J]. APPLIED PSYCHOLOGICAL MEASUREMENT, 1988, 12 (04) : 425 - 434
  • [9] Visual evoked potential latency predicts cognitive function in people with multiple sclerosis
    Covey, Thomas J.
    Golan, Daniel
    Doniger, Glen M.
    Sergott, Robert
    Zarif, Myassar
    Srinivasan, Jared
    Bumstead, Barbara
    Wilken, Jeffrey
    Buhse, Marijean
    Mebrahtu, Samson
    Gudesblatt, Mark
    [J]. JOURNAL OF NEUROLOGY, 2021, 268 (11) : 4311 - 4320
  • [10] Oliveira Maira Okada de, 2014, Dement. neuropsychol., V8, P112, DOI 10.1590/S1980-57642014DN82000005